Celera Licenses Bioinformatics Tools, Genomic Data To Its First Customer | GenomeWeb

ROCKVILLE, Md.--Celera Genomics has signed a five-year deal to provide Amgen with a subscription to its database products and access to associated bioinformatics systems and tools for viewing, browsing, and analyzing genomic information. Amgen, headquartered in Thousand Oaks, Calif., will also get early access to new genomic information generated by Celera.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.